Minneapolis-based Medtronic was founded in 1949 as a medical equipment repair shop by Earl Bakken and his brother-in-law, Palmer Hermundslie. The company has roughly 40,000 employees. 

The company reported worldwide revenue of $3.961 billion during Q3 2011 versus $3.851 billion during the same period of 2010.

Thus far in 2011, Medtronic has seen the FDA reject Amplify, a spine device that was linked to higher cancer malignancy than alternative procedures for degenerative disc disease patients. But it has also seen expansion in Asia with its opening facilities in Shanghai and Singapore.

At the end of 2010, Chairman and CEO William Hawkins announced his retirement as of April 29.

Tag:

Medtronic

Latest Headlines

Latest Headlines

Miss Idaho wears insulin pump in swimsuit competition

Miss Idaho is trending, but it has nothing to do with pageantry. The hashtag "show me your pump" became popular after newly crowned Sierra Sandison, diagnosed with Type I diabetes in 2012, was spotted on stage with her insulin pump by her side.

Medtronic could face legislative pushback in tax-inversion deal with Covidien

The Obama administration is cracking down on companies moving operations overseas for tax-inversion purposes, a move that could hold negative implications for Medtronic in its $43 billion proposed deal with Covidien.

Medtronic's Hospital of the Future akin to birthing an elephant

Tasked several years ago with forming a team to develop Medtronic's prototype Hospital of the Future, Director of IT Innovation Paul Thompson likened the process to the biology of birth--of an elephant, not salmon.

Covidien picks integration chief for Medtronic merger

As Covidien strides into a merger with Medtronic, the company last week announced the appointment of Bill Burke as CFO for Covidien Europe.

Study: Insulin pumps control glucose better than daily shots for Type 2 diabetics

Insulin pumps do a better job of helping control glucose levels in people with Type 2 diabetes than multiple daily injections, according to results from a new study funded by medical device maker Medtronic.

Exec talks on Covidien's fit with Medtronic

The president of Covidien's $1.6 billion vascular product group said that the impending merger with Medtronic was necessary from her perspective because being "a vascular player without cardiovascular, I think long term that would have been a real issue.

2013's 10 highest-paid Med Tech CEOs

With more M&A, product development and restructuring on the horizon, med tech CEOs have their work cut out for them in the coming year. But for now, here's the breakdown of what they took home in 2013.

Medtronic, Covidien chief integration officer talks about what the deal means

The leader of the looming integration effort facing Medtronic and Covidien stressed "balance sheet flexibility" as one of the main drivers of the $43 billion mega deal, and said it will lead to more M&A activity in early stage companies, although some investors disagree.

Implantable cardiac monitor better than standard stroke care, NEJM study finds

Continuous monitoring of stroke patients with an implantable monitor catches more potential problems than the standard, short-term cardiac monitoring. That's according to a study of the Reveal XT Insertable Cardiac Monitor (ICM) from Medtronic in a paper that was published recently in The New England Journal of Medicine.

Danaher demurs on M&A, looks to China, Brazil and Russia

Diversified conglomerate Danaher emphasized organic growth rather than acquisitions at a recent investor meeting. That's despite much speculation on its M&A appetite following the Medtronic announcement that it will acquire Covidien.